Clinical Trial Update: A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating the safety and efficacy of OLX72021 in healthy males with androgenetic alopecia, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• OLX72021 (OLX72021)

Snippet

Sponsor: Olix Pharmaceuticals, Inc. | Conditions: Androgenetic Alopecia (AGA) | Phase 1, Phase 2 | Status: RECRUITING